skip to main content

Our Private Equity Group provides trusted counsel derived from deep industry knowledge to established as well as up-and-coming private equity firms. We represent firms of every size across the spectrum of investment strategies, and we build long-standing relationships with our clients. As active participants in the private equity industry, we are able to advise our clients on the latest innovations, as well as current market practices and trends.

Kohlberg to Acquire PCI Pharma

Paul, Weiss is advising Kohlberg & Company, LLC in its acquisition of a majority stake in PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, from Partners Group, a global private markets investment manager.

Under the terms of the transaction, Mubadala Investment Company, an Abu Dhabi-based sovereign investor, will also become a significant investor in PCI. Kohlberg and Mubadala plan to partner with PCI's management team, to leverage the global growth trends in biologics and specialized drug therapies to grow specialized manufacturing and expand further into Asia and greater Europe. Financial terms of the transaction were not disclosed.

The Paul, Weiss team includes corporate partners Angelo Bonvino, Sarah Stasny and Thomas de la Bastide and counsel Julie Martinelli, David Harris and Suhan Shim; tax partners Lindsay Parks and Brad Okun; intellectual property partner Charles Googe; real estate partner Peter Fisch; litigation counsel Peter Jaffe; antitrust counsel Marta Kelly; international trade counsel Richard Elliott; environmental counsel William O'Brien; and employee benefits counsel Reuven Falik.

August 24, 2020

© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy